EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In vitro and in vivo characterization of a bat merbecovirus with ACE2- and DPP4-independent cell entry

Hiromichi Matsugo iD, Tomoya Kitamura iD, Naohiro Takahashi, James Chambers, Ayano Ichikawa, Misa Katayama, Kaixin Li, Wataru Sekine, Kosuke Ohira, Hiroho Ishida, Akiko Takenaka-Uema, Kazuyuki Uchida und 3 weitere

Journal of Virology · 2025

DOI: 10.1128/jvi.00727-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, 2025. Verfasst von Hiromichi Matsugo und 14 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Veterinary Microbiology, Graduate School of Agricultural and Life Sciences, University of Tokyo, Tokyo, Japan. Hauptthemen laut MEDLINE: Dipeptidyl Peptidase 4, Virus Internalization, Angiotensin-Converting Enzyme 2, Chiroptera. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Betacoronaviruses, which have caused three human outbreaks within the last two decades, are thought to originate from bats, raising the concern that bat coronaviruses could cause a novel human outbreak in the future. To determine whether the bat merbecovirus EjCoV-3 strain, previously detected in Eptesicus japonensis in Japan, has the potential to infect humans, we analyzed its cellular entry mechanism. Cellular entry of EjCoV-3 via the spike protein requires protease treatment and is mediated by an unknown receptor, other than DPP4 or ACE2. We generated cultivable recombinant EjCoV-3 using bacterial artificial chromosome-based reverse genetics and found that it efficiently replicated in human respiratory and intestinal cell cultures as well as nasal ciliated epithelium in hamsters. These findings suggest that bat merbecovirus with ACE2- and DPP4-independent cell entry has the potential to cause human infections, highlighting the importance of extensive bat surveillance for pandemic preparedness. IMPORTANCE Betacoronaviruses, including severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV), and SARS-CoV-2, have caused three significant outbreaks in the past two decades and are believed to have originated from bats. To investigate the potential for future outbreaks, we generated a Japanese bat-derived MERS-related coronavirus, designated EjCoV-3, using reverse genetics. Our results showed that EjCoV-3 does not utilize ACE2 and DPP4, cell entry receptors for SARS-CoV and MERS-CoV, as a means of infection. However, we found that EjCoV-3 is the first bat merbecovirus capable of efficiently replicating in human respiratory cells and the respiratory tract of hamsters. These findings provide new insight into the potential for MERS-related coronaviruses that do not use ACE2 and DPP4 to infect the human respiratory tract, highlighting the importance of preparedness for outbreaks caused by these viruses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dipeptidyl Peptidase 4Virus InternalizationAngiotensin-Converting Enzyme 2ChiropteraCoronavirus InfectionsCoronavirusAnimalsHumansCricetinaeSpike Glycoprotein, CoronavirusReceptors, VirusCell Line

Stichwörter der Autor:innen

batcoronavirusmerbecovirusreceptorreverse genetics

Substanzen

Dipeptidyl Peptidase 4Angiotensin-Converting Enzyme 2Spike Glycoprotein, CoronavirusReceptors, VirusDPP4 protein, humanACE2 protein, human

Autor:innen und Institutionen

  • Laboratory of Veterinary Microbiology, Graduate School of Agricultural and Life Sciences, University of Tokyo, Tokyo, Japan.
  • African Swine Fever Unit, National Agriculture and Food Research Organization (NARO), National Institute of Animal Health, Tokyo, Japan.
  • Laboratory of Veterinary Pathology, Graduate School of Agricultural and Life Sciences, University of Tokyo, Tokyo, Japan.
  • Department of Virology I, National Institute of Infectious Diseases, Tokyo, Japan.

ORCID-Profile: Hiromichi Matsugo, Tomoya Kitamura, Taisuke Horimoto, Shin Murakami

Förderung

  • Japan Agency for Medical Research and Development

Zitieren

APA

Matsugo, H., Kitamura, T., Takahashi, N., Chambers, J., Ichikawa, A., Katayama, M., Li, K., Sekine, W., Ohira, K., Ishida, H., Takenaka-Uema, A., Uchida, K., Shimojima, M., Horimoto, T., & Murakami, S. (2025). In vitro and in vivo characterization of a bat merbecovirus with ACE2- and DPP4-independent cell entry. Journal of Virology. https://doi.org/10.1128/jvi.00727-25

Vancouver

Matsugo H, Kitamura T, Takahashi N, Chambers J, Ichikawa A, Katayama M, et al. In vitro and in vivo characterization of a bat merbecovirus with ACE2- and DPP4-independent cell entry. Journal of Virology. 2025. doi:10.1128/jvi.00727-25

BibTeX
@article{Matsugo2025,
  author = {Matsugo, Hiromichi and Kitamura, Tomoya and Takahashi, Naohiro and Chambers, James and Ichikawa, Ayano and Katayama, Misa and Li, Kaixin and Sekine, Wataru and Ohira, Kosuke and Ishida, Hiroho and Takenaka-Uema, Akiko and Uchida, Kazuyuki and Shimojima, Masayuki and Horimoto, Taisuke and Murakami, Shin},
  title = {In vitro and in vivo characterization of a bat merbecovirus with ACE2- and DPP4-independent cell entry},
  journal = {Journal of Virology},
  year = {2025},
  doi = {10.1128/jvi.00727-25}
}
Kostenlos starten →